Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Therapy. Nucleic Acids|November 4, 2015
Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA QuantificationAmy Chan, Abigail Liebow, Makiko Yasuda, et al.
Hypertension (Dallas, Tex. : 1979)|April 30, 2019
Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver AngiotensinogenEstrellita Uijl, Katrina M Mirabito Colafella, Yuan Sun, et al.
Clinical Science (London, England : 1979)|January 6, 2021
No evidence for brain renin-angiotensin system activation during DOCA-salt hypertensionEstrellita Uijl, Liwei Ren, Katrina M Mirabito Colafella, et al.
British Journal of Pharmacology|September 15, 2022
Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetesEdwyn O Cruz-López, Liwei Ren, Estrellita Uijl, et al.
Hepatology (Baltimore, Md.)|September 29, 2006
Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytesSean E Doyle, Heidi Schreckhise, Kien Khuu-Duong, et al.
Hypertension (Dallas, Tex. : 1979)|March 15, 2021
Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney DiseaseDominique M Bovée, Liwei Ren, Estrellita Uijl, et al.
Nature Immunology|December 7, 2002
IL-28, IL-29 and their class II cytokine receptor IL-28RPaul Sheppard, Wayne Kindsvogel, Wenfeng Xu, et al.
Nature Immunology|June 9, 2004
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in miceStacey R Dillon, Cindy Sprecher, Angela Hammond, et al.
Nature Medicine|April 8, 2015
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophiliaAlfica Sehgal, Scott Barros, Lacramioara Ivanciu, et al.
Pageof 2